Strata Critical Medical (SRTA) Competitors

$5.33 +0.06 (+1.14%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$5.32 0.00 (-0.09%)

As of 09/25/2026 07:30 PM Eastern

SRTA vs. AGL, PNTG, INNV, AMN, and OMDA

Should you buy Strata Critical Medical stock or one of its competitors? Strata Critical Medical's main competitors and comparable companies include Agilon Health (AGL), The Pennant Group (PNTG), InnovAge (INNV), AMN Healthcare Services (AMN), and Omada Health (OMDA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Strata Critical Medical compare to Agilon Health?

Agilon Health (NYSE:AGL) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

47.4% of Strata Critical Medical shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 15.5% of Strata Critical Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Agilon Health currently has a consensus price target of $102.25, suggesting a potential upside of 26.76%. Strata Critical Medical has a consensus price target of $8.00, suggesting a potential upside of 50.09%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts clearly believe Strata Critical Medical is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Strata Critical Medical has lower revenue, but higher earnings than Agilon Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.23	-$391.35M	-$14.27	N/A
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A

Strata Critical Medical has a net margin of 15.71% compared to Agilon Health's net margin of -3.92%. Strata Critical Medical's return on equity of -2.97% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
Strata Critical Medical	15.71%	-2.97%	-2.54%

Agilon Health has a beta of 3.02, indicating that its share price is 202% more volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.26, indicating that its share price is 126% more volatile than the broader market.

In the previous week, Agilon Health had 5 more articles in the media than Strata Critical Medical. MarketBeat recorded 6 mentions for Agilon Health and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat Agilon Health's score of 0.62 indicating that Strata Critical Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Agilon Health	Positive
Strata Critical Medical	Very Positive

Summary

Strata Critical Medical beats Agilon Health on 12 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to The Pennant Group?

Strata Critical Medical (NASDAQ:SRTA) and The Pennant Group (NASDAQ:PNTG) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Strata Critical Medical has higher earnings, but lower revenue than The Pennant Group. Strata Critical Medical is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
The Pennant Group	$947.71M	1.50	$29.58M	$0.90	45.30

Strata Critical Medical has a net margin of 15.71% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
The Pennant Group	2.93%	10.33%	4.20%

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Comparatively, 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Strata Critical Medical has a beta of 2.26, indicating that its share price is 126% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Strata Critical Medical presently has a consensus price target of $8.00, indicating a potential upside of 50.09%. The Pennant Group has a consensus price target of $41.60, indicating a potential upside of 2.04%. Given Strata Critical Medical's higher possible upside, analysts clearly believe Strata Critical Medical is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

In the previous week, The Pennant Group had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 3 mentions for The Pennant Group and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat The Pennant Group's score of 0.92 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Strata Critical Medical	Very Positive
The Pennant Group	Positive

Summary

The Pennant Group beats Strata Critical Medical on 9 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to InnovAge?

Strata Critical Medical (NASDAQ:SRTA) and InnovAge (NASDAQ:INNV) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

In the previous week, InnovAge had 12 more articles in the media than Strata Critical Medical. MarketBeat recorded 13 mentions for InnovAge and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat InnovAge's score of 0.46 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Strata Critical Medical	Very Positive
InnovAge	Neutral

Strata Critical Medical has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Strata Critical Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
InnovAge	$989.71M	1.24	-$2.54M	-$0.02	N/A

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by company insiders. Comparatively, 1.0% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Strata Critical Medical currently has a consensus target price of $8.00, indicating a potential upside of 50.09%. InnovAge has a consensus target price of $10.50, indicating a potential upside of 16.67%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Strata Critical Medical is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Strata Critical Medical has a net margin of 15.71% compared to InnovAge's net margin of -0.26%. InnovAge's return on equity of -1.03% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
InnovAge	-0.26%	-1.03%	-0.47%

Strata Critical Medical has a beta of 2.26, indicating that its stock price is 126% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Summary

Strata Critical Medical beats InnovAge on 11 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to AMN Healthcare Services?

Strata Critical Medical (NASDAQ:SRTA) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Strata Critical Medical has a net margin of 15.71% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
AMN Healthcare Services	3.06%	19.92%	5.93%

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Strata Critical Medical currently has a consensus target price of $8.00, suggesting a potential upside of 50.09%. AMN Healthcare Services has a consensus target price of $36.00, suggesting a potential upside of 4.16%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Strata Critical Medical is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, AMN Healthcare Services had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 3 mentions for AMN Healthcare Services and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat AMN Healthcare Services' score of 0.81 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Strata Critical Medical	Very Positive
AMN Healthcare Services	Positive

Strata Critical Medical has higher earnings, but lower revenue than AMN Healthcare Services. Strata Critical Medical is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
AMN Healthcare Services	$2.73B	0.49	-$95.70M	$2.68	12.90

Strata Critical Medical has a beta of 2.26, meaning that its stock price is 126% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Summary

Strata Critical Medical beats AMN Healthcare Services on 9 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Omada Health?

Omada Health (NASDAQ:OMDA) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Omada Health currently has a consensus price target of $26.67, indicating a potential upside of 35.64%. Strata Critical Medical has a consensus price target of $8.00, indicating a potential upside of 50.09%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts clearly believe Strata Critical Medical is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

47.4% of Strata Critical Medical shares are owned by institutional investors. 6.4% of Omada Health shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Omada Health had 6 more articles in the media than Strata Critical Medical. MarketBeat recorded 7 mentions for Omada Health and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat Omada Health's score of 0.95 indicating that Strata Critical Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Omada Health	Positive
Strata Critical Medical	Very Positive

Strata Critical Medical has lower revenue, but higher earnings than Omada Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.63	-$12.78M	$0.05	393.20
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A

Omada Health has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.26, meaning that its share price is 126% more volatile than the broader market.

Strata Critical Medical has a net margin of 15.71% compared to Omada Health's net margin of 1.39%. Omada Health's return on equity of 2.60% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	1.39%	2.60%	1.98%
Strata Critical Medical	15.71%	-2.97%	-2.54%

Summary

Strata Critical Medical beats Omada Health on 9 of the 17 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTA vs. The Competition

Export

Metric	Strata Critical Medical	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$466.22M	$9.66B	$7.29B	$13.11B
Dividend Yield	N/A	2.60%	2.52%	13.51%
P/E Ratio	-133.25	35.06	275.27	25.78
Price / Sales	2.39	5.07	620.48	86.23
Price / Cash	N/A	120.27	79.23	52.93
Price / Book	1.66	5.25	10.44	6.30
Net Income	$41.35M	$315.70M	$3.50B	$360.35M
7 Day Performance	-0.19%	1.00%	-1.28%	-0.23%
1 Month Performance	-12.91%	-0.12%	-4.69%	-3.87%
1 Year Performance	N/A	16.95%	15.00%	5.38%

Strata Critical Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTA Strata Critical Medical	2.6329 of 5 stars	$5.33 +1.1%	$8.00 +50.1%	N/A	$466.22M	$197.14M	N/A	601	Positive News
AGL Agilon Health	2.5881 of 5 stars	$89.01 -3.4%	$102.25 +14.9%	+197.4%	$1.49B	$5.93B	N/A	856	News Coverage
PNTG The Pennant Group	2.6558 of 5 stars	$42.48 +6.3%	$41.60 -2.1%	+66.1%	$1.48B	$947.71M	47.20	9,700	High Trading Volume
INNV InnovAge	2.0899 of 5 stars	$10.85 -0.6%	$10.50 -3.2%	+87.9%	$1.48B	$989.71M	N/A	2,500
AMN AMN Healthcare Services	1.6241 of 5 stars	$34.93 +2.3%	$36.00 +3.1%	+93.4%	$1.35B	$2.73B	13.03	2,664

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTA) was last updated on 9/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Critical Medical (SRTA) Competitors

SRTA vs. AGL, PNTG, INNV, AMN, and OMDA

How does Strata Critical Medical compare to Agilon Health?

Summary

How does Strata Critical Medical compare to The Pennant Group?

Summary

How does Strata Critical Medical compare to InnovAge?

Summary

How does Strata Critical Medical compare to AMN Healthcare Services?

Summary

How does Strata Critical Medical compare to Omada Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Critical Medical (SRTA) Competitors

SRTA vs. AGL, PNTG, INNV, AMN, and OMDA

How does Strata Critical Medical compare to Agilon Health?

Do institutionals & insiders have more ownership in AGL or SRTA?

Do analysts prefer AGL or SRTA?

Which has higher earnings & valuation, AGL or SRTA?

Is AGL or SRTA more profitable?

Which has more risk and volatility, AGL or SRTA?

Does the media prefer AGL or SRTA?

Summary

How does Strata Critical Medical compare to The Pennant Group?

Which has stronger earnings & valuation, SRTA or PNTG?

Is SRTA or PNTG more profitable?

Do insiders and institutionals hold more shares of SRTA or PNTG?

Which has more risk & volatility, SRTA or PNTG?

Do analysts prefer SRTA or PNTG?

Does the media favor SRTA or PNTG?

Summary

How does Strata Critical Medical compare to InnovAge?

Does the media favor SRTA or INNV?

Which has better valuation & earnings, SRTA or INNV?

Do institutionals & insiders hold more shares of SRTA or INNV?

Do analysts rate SRTA or INNV?

Is SRTA or INNV more profitable?

Which has more risk and volatility, SRTA or INNV?

Summary

How does Strata Critical Medical compare to AMN Healthcare Services?

Is SRTA or AMN more profitable?

Do institutionals and insiders have more ownership in SRTA or AMN?

Do analysts prefer SRTA or AMN?

Does the media favor SRTA or AMN?

Which has stronger earnings & valuation, SRTA or AMN?

Which has more volatility & risk, SRTA or AMN?

Summary

How does Strata Critical Medical compare to Omada Health?

Do analysts prefer OMDA or SRTA?

Do insiders & institutionals hold more shares of OMDA or SRTA?

Does the media refer more to OMDA or SRTA?

Which has stronger valuation and earnings, OMDA or SRTA?

Which has more volatility and risk, OMDA or SRTA?

Is OMDA or SRTA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools